Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive–compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial

European Child and Adolescent Psychiatry

Volumn 24, Issue 5, 2015, Pages 591-602

  Skarphedinsson, Gudmundur ^a   Weidle, Bernhard ^b   Thomsen, Per Hove ^c   Dahl, Kitty ^a   Torp, Nor Christian ^a   Nissen, Judith B ^c   Melin, Karin Holmgren ^d   Hybel, Katja ^c   Valderhaug, Robert ^b   Wentzel Larsen, Tore ^a   Compton, Scott N ^e   Ivarsson, Tord ^a  

^a Regional Centre of Child and Adolescent Mental Health   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Children and adolescents; Cognitive behavior therapy; Obsessive compulsive disorder; Selective serotonin reuptake inhibitors; Sertraline; Treatment outcome

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; CHILD; COGNITIVE THERAPY; CONTROLLED STUDY; DENMARK; FEMALE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; NORWAY; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SWEDEN; TREATMENT OUTCOME;

ADOLESCENT; CHILD; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DENMARK; FEMALE; HUMANS; MALE; NORWAY; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SWEDEN; TREATMENT OUTCOME;

EID: 84939961024     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-014-0613-0     Document Type: Article

References (54)

1. AACAP (2012) Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 51:98–113
2. Abramowitz J, Whiteside S, Deacon B (2005) The effectiveness of treatment for pediatric obsessive-compulsive disorder: a meta-analysis. Behav Ther 36:55–63
3. Allison PD. SAS Macros. http://www.statisticalhorizons.com/wp-content/uploads/2012/01/combchi.sas (Updated December 17, 2007). Accessed 29 Jan 2014
4. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth Edition (Text Revision). American Psychiatric Association, Washington, DC
5. Bjorgvinsson T, Wetterneck CT, Powell DM, Chasson GS, Webb SA, Hart J, Heffelfinger S, Azzouz R, Entricht TL, Davidson JE, Stanley MA (2008) Treatment outcome for adolescent obsessive-compulsive disorder in a specialized hospital setting. J Psychiatric Pract 14:137–145
6. Carpenter J, Kenward M (2013) Multiple imputation and its application. Wiley, West Sussex
7. Cook EH, Wagner KD, March JS, Biederman J, Landau P, Wolkow R, Messig M (2001) Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 40:1175–1181
8. Cottraux J, Note I, Yao SN, Lafont S, Note B, Mollard E, Bouvard M, Sauteraud A, Bourgeois M, Dartigues JF (2001) A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorder. Psychother Psychosom 70:288–297
9. Fisher PL, Wells A (2005) How effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis. Behav Res Ther 43:1543–1558
10. Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Mellstrom B, Linnoila M (1985) Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study. Arch Gen Psychiatry 42:977–983
11. Flament MF, Whitaker A, Rapoport JL, Davies M, Berg CZ, Kalikow K, Sceery W, Shaffer D (1988) Obsessive compulsive disorder in adolescence: an epidemiological study. J Am Acad Child Adolesc Psychiatry 27:764–771
12. Franklin ME, Sapyta J, Freeman JB, Khanna M, Compton S, Almirall D, Moore P, Choate-Summers M, Garcia A, Edson AL, Foa EB, March JS (2011) Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. JAMA 306:1224–1232
13. Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, Faraone SV (2003) Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry 160:1919–1928
14. Geller DA, Hoog SL, Heiligenstein JH, Ricardi RK, Tamura R, Kluszynski S, Jacobson JG, Fluoxetine Pediatric OCD Study Team (2001) Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial. J Am Acad Child Adolesc Psychiatry 40:773–779
15. Gilliam CM, Diefenbach GJ, Whiting SE, Tolin DF (2010) Stepped care for obsessive-compulsive disorder: an open trial. Behav Res Ther 48:1144–1149
16. Graham JW, Olchowski AE, Gilreath TD (2007) How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev Sci 8:206–213
17. Grant PJ, Joseph LA, Farmer CA, Luckenbaugh DA, Lougee LC, Zarate CA, Swedo SE (2014) 12-week placebo-controlled trial of add-on riluzole in the treatment of childhood-onset obsessive compulsive disorder. Neuropsychopharmacology 6:1453–1459
18. Ivarsson T, Thomsen PH, Dahl K, Valderhaug R, Weidle B, Nissen JB, Englyst I, Christensen K, Torp NC, Melin K (2010) The rationale and some features of the Nordic Long-Term OCD Treatment Study (NordLOTS) in childhood and adolescence. Child Youth Care Forum 39:91–99
19. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N (1997) Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980–988
20. Kutcher S (1997) Practitioner review: the pharmacotherapy of adolescent depression. J Child Psychol Psychiatry 38:755–767
21. March JS, Biederman J, Wolkow R, Safferman A, Mardekian J, Cook EH, Cutler NR, Dominguez R, Ferguson J, Muller B, Riesenberg R, Rosenthal M, Sallee FR, Wagner KD, Steiner H (1998) Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA 280:1752–1756
22. March JS, Franklin ME, Leonard H, Garcia A, Moore P, Freeman J, Foa E (2007) Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry 61:344–347
23. Micali N, Heyman I, Perez M, Hilton K, Nakatani E, Turner C, Mataix-Cols D (2010) Long-term outcomes of obsessive-compulsive disorder: follow-up of 142 children and adolescents. Br J Psychiatry 197:128–134
24. Morris SB, DeShon RP (2002) Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychol Methods 7:105–125
25. Murray CJL, López AD (eds) (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Harvard University Press, Cambridge
26. National Institute for Heath and Clinical Excellence (2005) Obsessive compulsive disorder (OCD) and body dysmorphic disorder (BDD). In: Excellence NIfHaC (ed) National Institute for Health and Clinical Excellence, London, p National Institute for Health and Clinical Excellence
27. Olatunji BO, Rosenfield D, Tart CD, Cottraux J, Powers MB, Smits JA (2013) Behavioral versus cognitive treatment of obsessive-compulsive disorder: an examination of outcome and mediators of change. J Consult Clin Psychol 81:415–428
28. Piacentini J, Bergman RL, Chang S, Langley A, Peris T, Wood JJ, McCracken J (2011) Controlled comparison of family cognitive behavioral therapy and psychoeducation/relaxation training for child obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 50:1149–1161
29. Piacentini J, Peris TS, Bergman RL, Chang S, Jaffer M (2007) Functional impairment in childhood OCD: development and psychometrics properties of the Child Obsessive-Compulsive Impact Scale-Revised (COIS-R). J Clin Child Adolesc Psychol 36:645–653
30. POTS Study Team (2004) Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 292:1969–1976
31. Raghunathan TE, Lepkowski JM, Van Hoewyk J, Solenberger P (2001) A multivariate technique for multiply imputing missing values using a sequence of regression models. Survey Methodol 27:85–96
32. Rapoport JL, Inoff-Germain G, Weissman MM, Greenwald S, Narrow WE, Jensen PS, Lahey BB, Canino G (2000) Childhood obsessive-compulsive disorder in the NIMH MECA study: parent versus child identification of cases. Methods for the Epidemiology of Child and Adolescent Mental Disorders. J Anxiety Disord 14:535–548
33. Rasmussen SA, Eisen JL (1992) The epidemiology and clinical features of obsessive compulsive disorder. Psychiatr Clin North Am 15:743–758
34. Rasmussen SA, Eisen JL (1990) Epidemiology of obsessive compulsive disorder. J Clin Psychiatry 51(Suppl):10–13 (discussion 14)
35. Riddle MA, Reeve EA, Yaryura-Tobias JA, Yang HM, Claghorn JL, Gaffney G, Greist JH, Holland D, McConville BJ, Pigott T, Walkup JT (2001) Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. J Am Acad Child Adolesc Psychiatry 40:222–229
36. Rubin DB (2004) Multiple imputation for nonresponse in surveys. Wiley Inter-Science, New York
37. Ruscio AM, Stein DJ, Chiu WT, Kessler RC (2010) The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry 15:53–63
38. Ryan SE, Porth LS (2007) A tutorial on the piecewise regression approach applied to bedload transport data. General Technical Report RMRS-GTR-189. In: Department of Agriculture FS, Rocky Mountain Research Station (ed) Fort Collins, p 41
39. Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, Cicchetti D, Leckman JF (1997) Children’s Yale–Brown obsessive compulsive scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 36:844–852
40. Singer JD, Willett JB (2003) Applied longitudinal data analysis: modeling change and event occurrence. Oxford University Press, Oxford
41. Stewart SE, Geller DA, Jenike M, Pauls D, Shaw D, Mullin B, Faraone SV (2004) Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatr Scand 110:4–13
42. Storch EA, Bussing R, Small BJ, Geffken GR, McNamara JP, Rahman O, Lewin AB, Garvan CS, Goodman WK, Murphy TK (2013) Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive–compulsive disorder. Behav Res Ther 51:823–829
43. Storch EA, Lehmkuhl HD, Ricketts E, Geffken GR, Marien W, Murphy TK (2010) An open trial of intensive family based cognitive-behavioral therapy in youth with obsessive-compulsive disorder who are medication partial responders or nonresponders. J Clin Child Adolesc Psychol 39:260–268
44. Storch EA, Lewin AB, De Nadai AS, Murphy TK (2010) Defining treatment response and remission in obsessive-compulsive disorder: a signal detection analysis of the Children’s Yale–Brown Obsessive Compulsive Scale. J Am Acad Child Adolesc Psychiatry 49:708–717
45. Thomsen PH, Torp NC, Dahl K, Christensen K, Englyst I, Melin KH, Nissen JB, Hybel KA, Valderhaug R, Weidle B, Skarphedinsson G, von Bahr PL, Ivarsson T (2013) The Nordic long-term OCD treatment study (NordLOTS): rationale, design, and methods. Child Adolesc Psychiatry Mental Health (Electronic Resource) 7:41
46. Tolin DF, Diefenbach GJ, Gilliam CM (2011) Stepped care versus standard cognitive-behavioral therapy for obsessive-compulsive disorder: a preliminary study of efficacy and costs. Depress Anxiety 28:314–323
47. Torp NC, Dahl K, Skarphedinsson G, Thomsen P, Valderhaug R, Weidle B, Melin K, Hybel K, Lenhard F, Wentzel-Larsen T, Franklin M, Ivarsson T (2014) Effectiveness of cognitive behavior treatment for pediatric Obsessive–Compulsive Disorder: Acute outcomes from the Nordic Long-term OCD Treatment Study (NordLOTS). Manuscript submitted for publication
48. U.S. Food and Drug Administration (2012) What is a serious adverse event. In: U.S. Food and Drug Administration, Silver Spring
49. Valderhaug R, Ivarsson T (2005) Functional impairment in clinical samples of Norwegian and Swedish children and adolescents with obsessive-compulsive disorder. Eur Child Adolesc Psychiatry 14:164–173
50. Valleni-Basile LA, Garrison CZ, Jackson KL, Waller JL, McKeown RE, Addy CL, Cuffe SP (1994) Frequency of obsessive-compulsive disorder in a community sample of young adolescents. (Erratum appears in J Am Acad Child Adolesc Psychiatry. 1995 Feb, 34(2), pp 128–9; PMID: 7896644). J Am Acad Child Adolesc Psychiatry 33:782–791
51. van Balkom AJ, Emmelkamp PMG, Eikelenboom M, Hoogendoorn AW, Smit JH, van Oppen P (2012) Cognitive Therapy versus fluvoxamine as a second-step treatment in obsessive–compulsive disorder nonresponsive to first-step behavior therapy. Psychother Psychosom 81:366–374
52. van Oppen P, de Haan E, van Balkom AJ, Spinhoven P, Hoogduin K, van Dyck R (1995) Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder. Behav Res Ther 33:379–390
53. Wagner KD, Cook EH, Chung H, Messig M (2003) Remission status after long-term sertraline treatment of pediatric obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 13(Suppl 1):S53–S60
54. Watson HJ, Rees CS (2008) Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder. J Child Psychol Psychiatry 49:489–498